Nonsense Mutations in BAG3 are Associated With Early-Onset Dilated Cardiomyopathy in French Canadians

Canadian Journal of Cardiology

Volumn 30, Issue 12, 2014, Pages 1655-1661

  Chami, Nathalie ^a,b   Tadros, Rafik ^a,b   Lemarbre, François ^a   Lo, Ken Sin ^a   Beaudoin, Mélissa ^a   Robb, Laura ^a   Labuda, Damian ^b,c   Tardif, Jean Claude ^a,b   Racine, Normand ^a,b   Talajic, Mario ^a,b   Lettre, Guillaume ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BAG3 GENE; CANADIAN; CLINICAL ARTICLE; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DSP GENE; EXOME; FAMILY; FEMALE; GENE; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LINKAGE ANALYSIS; LMNA GENE; MALE; MIDDLE AGED; MYH7 GENE; MYPN GENE; NONSENSE MUTATION; ONSET AGE; PREVALENCE; PROGNOSIS; RBM20 GENE; SEGREGATION ANALYSIS; STATISTICAL ANALYSIS; TNNT2 GENE; TTN GENE; CANADA; EPIDEMIOLOGY; ETHNOLOGY; FRANCE; GENETIC LINKAGE; GENETICS; HETEROZYGOTE; METABOLISM; NUCLEOTIDE SEQUENCE; PEDIGREE; PHENOTYPE; STOP CODON;

APOPTOSIS REGULATORY PROTEIN; BAG3 PROTEIN, HUMAN; DNA; SIGNAL TRANSDUCING ADAPTOR PROTEIN; STOP CODON;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGE OF ONSET; APOPTOSIS REGULATORY PROTEINS; CANADA; CARDIOMYOPATHY, DILATED; CODON, NONSENSE; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; FRANCE; GENETIC LINKAGE; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PHENOTYPE;

EID: 84919846033     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.09.030     Document Type: Article

References (37)

1. Yusen R.D., Christie J.D., Edwards L.B., et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Adult Lung and Heart-Lung Transplant Report-2013; focus theme: age. JHeart Lung Transplant 2013, 32:965-978.
2. Michels V.V., Driscoll D.J., Miller F.A. Familial aggregation of idiopathic dilated cardiomyopathy. Am J Cardiol 1985, 55:1232-1233.
3. Goerss J.B., Michels V.V., Burnett J., et al. Frequency of familial dilated cardiomyopathy. Eur Heart J 1995, 16(suppl O):2-4.
4. Mestroni L., Rocco C., Gregori D., et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. JAm Coll Cardiol 1999, 34:181-190.
5. Kimura A. Contribution of genetic factors to the pathogenesis of dilated cardiomyopathy: the cause of dilated cardiomyopathy: genetic or acquired? (genetic-side). Circ J 2011, 75:1756-1765.
6. Hershberger R.E., Hedges D.J., Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol 2013, 10:531-547.
7. Ackerman MJ, Priori SG, Willems S, etal. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. 2011;13:1077-1109.
8. Gollob M.H., Blier L., Brugada R., et al. Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. Can J Cardiol 2011, 27:232-245.
9. Limongelli G., Elliott P., Charron P., Mogensen J., McKeown P.P. Approaching genetic testing in cardiomyopathies 2012, European Society of Cardiology Council for Cardiology Practice, Available at, http://www.escardio.org/communities/councils/ccp/e-journal/volume11/Pages/genetic-testing-cardiomyopathy.aspx#.VC2x-2d0ypo, accessed April 1, 2014.
10. Ng S.B., Turner E.H., Robertson P.D., et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009, 461:272-276.
11. Musunuru K., Pirruccello J.P., Do R., et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. NEngl J Med 2010, 363:2220-2227.
12. Sankaran V.G., Ghazvinian R., Do R., et al. Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. JClin Invest 2012, 122:2439-2443.
13. Mestroni L., Maisch B., McKenna W.J., et al. Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J 1999, 20:93-102.
14. Moreau C., Vezina H., Yotova V., et al. Genetic heterogeneity in regional populations of Quebec-parental lineages in the Gaspe Peninsula. Am J Phys Anthropol 2009, 139:512-522.
15. Abecasis G.R., Cherny S.S., Cookson W.O., Cardon L.R. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002, 30:97-101.
16. Codd M.B., Sugrue D.D., Gersh B.J., Melton L.J. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation 1989, 80:564-572.
17. R: A language and Environment for Statistical Computing; R Core Team. R Foundation for Statistical Computing 2013, R core Team, Vienna, Austria, Available at: http://www.R-project.org. Accessed April 2014.
18. Purcell S., Neale B., Todd-Brown K., et al. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 2007, 81.
19. Sherry S.T., Ward M.H., Kholodov M., et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001, 29:308-311.
20. Abecasis G.R., Auton A., Brooks L.D., et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012, 491:56-65.
21. Fu W., O'Connor T.D., Jun G., et al. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature 2013, 493:216-220.
22. Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. JAm Coll Cardiol 2013, 62:e147-239.
23. Villard E., Perret C., Gary F., et al. Agenome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J 2011, 32:1065-1076.
24. Brauch K.M., Karst M.L., Herron K.J., et al. Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. JAm Coll Cardiol 2009, 54:930-941.
25. Wells Q.S., Becker J.R., Su Y.R., et al. Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy. Cir Cardiovasc Genet 2013, 6:317-326.
26. Hishiya A., Kitazawa T., Takayama S. BAG3 and Hsc70 interact with actin capping protein CapZ to maintain myofibrillar integrity under mechanical stress. Circ Res 2010, 107:1220-1231.
27. Norton N., Li D., Rieder M.J., et al. Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am J Hum Genet 2011, 88:273-282.
28. Feldman A.M., Begay R.L., Knezevic T., et al. Decreased levels of BAG3 in a family with a rare variant and in idiopathic dilated cardiomyopathy. JCell Physiol 2014, 229:1697-1702.
29. Campbell N., Sinagra G., Jones K.L., et al. Whole exome sequencing identifies a troponin T mutation hot spot in familial dilated cardiomyopathy. PloS One 2013, 8:e78104.
30. Akalin N., Zietkiewicz E., Makalowski W., Labuda D. Are CpG sites mutation hot spots in the dystrophin gene?. Hum Mol Genet 1994, 3:1425-1426.
31. Siu B.L., Niimura H., Osborne J.A., et al. Familial dilated cardiomyopathy locus maps to chromosome 2q31. Circulation 1999, 99:1022-1026.
32. Gerull B., Gramlich M., Atherton J., et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 2002, 30:201-204.
33. Gerull B., Atherton J., Geupel A., et al. Identification of a novel frameshift mutation in the giant muscle filament titin in a large Australian family with dilated cardiomyopathy. JMol Med (Berl) 2006, 84:478-483.
34. Norton N., Li D., Rampersaud E., et al. Exome sequencing and genome-wide linkage analysis in 17 families illustrate the complex contribution of TTN truncating variants to dilated cardiomyopathy. Circ Cardiovasc Genet 2013, 6:144-153.
35. Herman D.S., Lam L., Taylor M.R., et al. Truncations of titin causing dilated cardiomyopathy. NEngl J Med 2012, 366:619-628.
36. Norton N., Robertson P.D., Rieder M.J., et al. Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era. Circ Cardiovasc Genet 2012, 5:167-174.
37. Pugh T.J., Kelly M.A., Gowrisankar S., et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med 2014, 16:601-608.